Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra.
about
Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater.A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.Identification of substances migrating from plastic baby bottles using a combination of low-resolution and high-resolution mass spectrometric analysers coupled to gas and liquid chromatography.Fragmentation of toxicologically relevant drugs in negative-ion liquid chromatography-tandem mass spectrometry.Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonaAnalysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach.Detection and mapping of illicit drugs and their metabolites in fingermarks by MALDI MS and compatibility with forensic techniques.Direct drug analysis from oral fluid using medical swab touch spray mass spectrometry.Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.Current use of high-resolution mass spectrometry in the environmental sciences.Aggressive dereplication using UHPLC-DAD-QTOF: screening extracts for up to 3000 fungal secondary metabolites.Wide-range screening of psychoactive substances by FIA-HRMS: identification strategies.Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan.Pitfall in cannabinoid analysis--detection of a previously unrecognized interfering compound in human serum.Determination of ecgonine and seven other cocaine metabolites in human urine and whole blood by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry.The persistence of illicit drug smoke residues and their recovery from common household surfaces.A tutorial in small molecule identification via electrospray ionization-mass spectrometry: The practical art of structural elucidation.Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine.The analysis of latent fingermarks on polymer banknotes using MALDI-MS.Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening
P2860
Q30244453-4C5D9720-192F-43EB-B422-C19042231CF0Q30995949-7DBB058E-9CFD-4F6E-AF62-1B4EFCF55163Q33466406-449A2D16-99D6-4BC2-A837-E93D52494E20Q34350577-635B6757-1927-4DEF-A99C-19AF9A0F731DQ34499556-EB0EA07D-3760-4932-8793-31597229EE44Q34504951-66A170BC-1418-42B7-8509-8BE7195093CEQ35168771-219362DF-3F79-42A3-A7F8-A158E084AF6BQ35676517-88CD7E52-2983-437D-BB0F-E98ED415FBC8Q35885493-BD9EA9AA-6095-4EB0-97F2-A4771A86452BQ35917163-07B2808D-E414-452A-B0FD-D705803E5D26Q37987851-C8654C58-6162-48F9-8B60-016337026DB2Q38284217-B8D2B700-3B06-4CDD-8389-FBB195856039Q41089737-0EC9EFD8-9849-441E-910D-1C49CE93699DQ44758844-710218A6-2BE7-47B7-94E3-40F64D6E4911Q45164178-E2F16E9B-5FD2-460F-82F9-B2446F437DC5Q46087627-57866437-E7F6-43C0-9EEC-FBCFD6E496C0Q47417536-6BEF515F-AF06-45C5-A1D5-91C0C3BE9220Q47614283-0695223D-3FF4-4B39-9BA1-AF6ABB3D8E0CQ47907013-9A917FB8-F7E0-4815-AA15-AAB60B770B4DQ55263341-B6ACB534-22DD-43BF-897A-89E3C4ACB010Q57212798-32312357-6B33-4926-A367-FB0707C7F27B
P2860
Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS
@nl
Fragmentation pathways of drug ...... d MS(E) accurate-mass spectra.
@en
type
label
Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS
@nl
Fragmentation pathways of drug ...... d MS(E) accurate-mass spectra.
@en
prefLabel
Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS
@nl
Fragmentation pathways of drug ...... d MS(E) accurate-mass spectra.
@en
P2860
P50
P356
P1476
Fragmentation pathways of drug ...... nd MS(E) accurate-mass spectra
@en
P2093
Félix Hernández
Lubertus Bijlsma
P2860
P304
P356
10.1002/JMS.1963
P577
2011-09-01T00:00:00Z